Page last updated: 2024-10-28

ibuprofen and Protein-Losing Enteropathies

ibuprofen has been researched along with Protein-Losing Enteropathies in 1 studies

Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine

Protein-Losing Enteropathies: Pathological conditions in the INTESTINES that are characterized by the gastrointestinal loss of serum proteins, including SERUM ALBUMIN; IMMUNOGLOBULINS; and at times LYMPHOCYTES. Severe condition can result in HYPOGAMMAGLOBULINEMIA or LYMPHOPENIA. Protein-losing enteropathies are associated with a number of diseases including INTESTINAL LYMPHANGIECTASIS; WHIPPLE'S DISEASE; and NEOPLASMS of the SMALL INTESTINE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zardawi, IM1
Prematilake, S1

Other Studies

1 other study available for ibuprofen and Protein-Losing Enteropathies

ArticleYear
NSAID-associated protein losing enteropathy with fatal outcome.
    Pathology, 2012, Volume: 44, Issue:5

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Fatal Outcome; Female; Humans; Ibuprofen; Protein-Lo

2012